<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01195077</url>
  </required_header>
  <id_info>
    <org_study_id>Dietary Algae and HIV</org_study_id>
    <nct_id>NCT01195077</nct_id>
  </id_info>
  <brief_title>Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?</brief_title>
  <acronym>HIV</acronym>
  <official_title>Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Drawing inferences from epidemiologic studies of HIV/AIDS as well well as cell culture and
      animal studies of HIV inhibition by algae, we propose algal consumption as one unifying
      characteristic of countries with anomalously low rates. HIV/AIDS incidence and prevalence in
      Eastern Asia (&lt;1/10,000 adults in Japan and Korea), compared to Africa (≈1/10 adults)
      strongly suggest that differences in IV drug use and sexual behavior are insufficient to
      explain the 1000-fold variation. Even in Africa, AIDS/HIV rates vary. Spirulina is part of
      the daily diet for many people living in Chad, where prevalence of HIV has remained at less
      than 4% for more than 20 years. Average daily algae consumption in Asia and Africa ranges
      between 1 to 2 tablespoons (3 - 13 grams).

      HIV viral load is the main indicator of infection, however CD4 helper cell counts are most
      predictive of morbidity and mortality.We hypothesized that the consumption of algae could be
      important in diminishing the risk of HIV infection, and subsequent progression, possibly by
      enhancing the immune response.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twelve HIV+ patients not on antiretroviral therapy were clinically evaluated and enrolled in
      the three-week study. Subjects received 10 algae capsules/d. Laboratory tests of CD4 counts
      and HIV RNA were performed at baseline, week 1, week 2, and week 3, and then once a month.
      Six subjects continued for between 4 and 14 months. In addition to CD4 lymphocyte counts and
      viral loads, subjects were evaluated monthly for Complete Blood Counts (CBC), Liver profile,
      Basic Metabolic Panel, and some subjects were evaluated for thyroid function and cholesterol.
      All subjects completed standard HIV Quality of Life questionnaires at each clinic visit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2003</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dietary algae influence on CD4 helper cells and HIV viral load</measure>
    <time_frame>Once a week for first 3 weeks, then once a month</time_frame>
    <description>The first 6 subjects participated for 3 weeks. After analysis of the results, it was determined that there were no side effects and some indication of benefit. The next 6 subjects participated for up to 14 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Would seaweed (Undaria) or spirulina or a combination of the two algae have more benefit?</measure>
    <time_frame>Participants were randomized to one of 3 treatments.</time_frame>
    <description>The combination of the 2 algae appeared to have more benefit. However, the sample size was too small to make conclusions.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Seaweed, Spirulina, Seaweed + Spirulina</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized to:
Arm 1: Seaweed. Ten capsules of .5 grams per capsule for a total of 10 grams per day.
Arm 2: Spirulina: Ten capsules of .5 grams per capsule for a total of 10 grams per day.
Arm 3: Seaweed: (2.5 grams) plus Spirulina (2.5 grams). Ten capsules of .5 grams per capsule for a total of 10 grams per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>seaweed, spirulina, seaweed + spirulina</intervention_name>
    <description>Arm 1: Seaweed. Ten capsules of .5 grams per capsule for a total of 10 grams per day.
Arm 2: Spirulina: Ten capsules of .5 grams per capsule for a total of 10 grams per day.
Arm 3: Seaweed: (2.5 grams) plus Spirulina (2.5 grams). Ten capsules of .5 grams per capsule for a total of 10 grams per day.
Spirulina: Ten capsules of .5 grams per capsule for a total of 10 grams per day.</description>
    <arm_group_label>Seaweed, Spirulina, Seaweed + Spirulina</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of HIV

          -  Able to swallow pills

        Exclusion Criteria:

          -  Allergy to iodine/seafood

          -  Thyroid disease

          -  Not taking antiretroviral therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jane Teas, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cancer Prevention and Control Program/University of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Trinchero J, Ponce NM, Córdoba OL, Flores ML, Pampuro S, Stortz CA, Salomón H, Turk G. Antiretroviral activity of fucoidans extracted from the brown seaweed Adenocystis utricularis. Phytother Res. 2009 May;23(5):707-12. doi: 10.1002/ptr.2723.</citation>
    <PMID>19107862</PMID>
  </results_reference>
  <results_reference>
    <citation>Damonte EB, Matulewicz MC, Cerezo AS. Sulfated seaweed polysaccharides as antiviral agents. Curr Med Chem. 2004 Sep;11(18):2399-419. Review.</citation>
    <PMID>15379705</PMID>
  </results_reference>
  <results_reference>
    <citation>Pereira HS, Leão-Ferreira LR, Moussatché N, Teixeira VL, Cavalcanti DN, Costa LJ, Diaz R, Frugulhetti IC. Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 2004 Oct;64(1):69-76.</citation>
    <PMID>15451181</PMID>
  </results_reference>
  <results_reference>
    <citation>Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE; Consorzio Interuniversitario Nazionale per la Bio-Oncologia, Italy. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology. 2007 May;17(5):541-52. Epub 2007 Feb 12.</citation>
    <PMID>17296677</PMID>
  </results_reference>
  <results_reference>
    <citation>Rechter S, König T, Auerochs S, Thulke S, Walter H, Dörnenburg H, Walter C, Marschall M. Antiviral activity of Arthrospira-derived spirulan-like substances. Antiviral Res. 2006 Dec;72(3):197-206. Epub 2006 Jun 30.</citation>
    <PMID>16884788</PMID>
  </results_reference>
  <results_reference>
    <citation>Buffa V, Stieh D, Mamhood N, Hu Q, Fletcher P, Shattock RJ. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models. J Gen Virol. 2009 Jan;90(Pt 1):234-43. doi: 10.1099/vir.0.004358-0.</citation>
    <PMID>19088294</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang H, Ooi EV, Ang PO Jr. Antiviral activities of extracts from Hong Kong seaweeds. J Zhejiang Univ Sci B. 2008 Dec;9(12):969-76. doi: 10.1631/jzus.B0820154.</citation>
    <PMID>19067465</PMID>
  </results_reference>
  <results_reference>
    <citation>Artan M, Li Y, Karadeniz F, Lee SH, Kim MM, Kim SK. Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava. Bioorg Med Chem. 2008 Sep 1;16(17):7921-6. doi: 10.1016/j.bmc.2008.07.078. Epub 2008 Jul 29.</citation>
    <PMID>18693022</PMID>
  </results_reference>
  <results_reference>
    <citation>Queiroz KC, Medeiros VP, Queiroz LS, Abreu LR, Rocha HA, Ferreira CV, Jucá MB, Aoyama H, Leite EL. Inhibition of reverse transcriptase activity of HIV by polysaccharides of brown algae. Biomed Pharmacother. 2008 Jun;62(5):303-7. doi: 10.1016/j.biopha.2008.03.006. Epub 2008 Apr 4.</citation>
    <PMID>18455359</PMID>
  </results_reference>
  <results_reference>
    <citation>Gideon TP, Rengasamy R. Toxicological evaluation of fucoidan from Cladosiphon okamuranus. J Med Food. 2008 Dec;11(4):638-42. doi: 10.1089/jmf.2007.0127.</citation>
    <PMID>19053854</PMID>
  </results_reference>
  <results_reference>
    <citation>Paskaleva EE, Lin X, Duus K, McSharry JJ, Veille JC, Thornber C, Liu Y, Lee DY, Canki M. Sargassum fusiforme fraction is a potent and specific inhibitor of HIV-1 fusion and reverse transcriptase. Virol J. 2008 Jan 15;5:8. doi: 10.1186/1743-422X-5-8.</citation>
    <PMID>18197976</PMID>
  </results_reference>
  <results_reference>
    <citation>Paskaleva EE, Lin X, Li W, Cotter R, Klein MT, Roberge E, Yu EK, Clark B, Veille JC, Liu Y, Lee DY, Canki M. Inhibition of highly productive HIV-1 infection in T cells, primary human macrophages, microglia, and astrocytes by Sargassum fusiforme. AIDS Res Ther. 2006 May 25;3:15.</citation>
    <PMID>16725040</PMID>
  </results_reference>
  <results_reference>
    <citation>Ahn MJ, Yoon KD, Kim CY, Kim JH, Shin CG, Kim J. Inhibitory activity on HIV-1 reverse transcriptase and integrase of a carmalol derivative from a brown Alga, Ishige okamurae. Phytother Res. 2006 Aug;20(8):711-3.</citation>
    <PMID>16775811</PMID>
  </results_reference>
  <results_reference>
    <citation>Ahn MJ, Yoon KD, Min SY, Lee JS, Kim JH, Kim TG, Kim SH, Kim NG, Huh H, Kim J. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol Pharm Bull. 2004 Apr;27(4):544-7.</citation>
    <PMID>15056863</PMID>
  </results_reference>
  <results_reference>
    <citation>Simpore J, Zongo F, Kabore F, Dansou D, Bere A, Nikiema JB, Pignatelli S, Biondi DM, Ruberto G, Musumeci S. Nutrition rehabilitation of HIV-infected and HIV-negative undernourished children utilizing spirulina. Ann Nutr Metab. 2005 Nov-Dec;49(6):373-80. Epub 2005 Oct 11.</citation>
    <PMID>16219988</PMID>
  </results_reference>
  <results_reference>
    <citation>Simpore J, Kabore F, Zongo F, Dansou D, Bere A, Pignatelli S, Biondi DM, Ruberto G, Musumeci S. Nutrition rehabilitation of undernourished children utilizing Spiruline and Misola. Nutr J. 2006 Jan 23;5:3.</citation>
    <PMID>16430775</PMID>
  </results_reference>
  <results_reference>
    <citation>Yamani E, Kaba-Mebri J, Mouala C, Gresenguet G, Rey JL. [Use of spirulina supplement for nutritional management of HIV-infected patients: study in Bangui, Central African Republic]. Med Trop (Mars). 2009 Feb;69(1):66-70. French.</citation>
    <PMID>19499738</PMID>
  </results_reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2010</study_first_submitted>
  <study_first_submitted_qc>September 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2010</study_first_posted>
  <last_update_submitted>April 2, 2015</last_update_submitted>
  <last_update_submitted_qc>April 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Dietary intervention</keyword>
  <keyword>Algae</keyword>
  <keyword>HIV progression</keyword>
  <keyword>Algae specific kind</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

